Compound 1407
Identifiers
- Canonical SMILES:
CN1CCN(CC[C@H](CSc2ccccc2F)Nc2ccc(cc2S(=O)(=O)C(F)(F)F)S(=O)(=O)Nc2ncnc3CN(CCc23)C2CCN(Cc3ccccc3-c3ccc(Cl)cc3)CC2)CC1
- InChi:
InChI=1S/C47H53ClF4N8O4S3/c1-57-24-26-58(27-25-57)20-16-36(31-65-44-9-5-4-8-41(44)49)55-42-15-14-38(28-45(42)66(61,62)47(50,51)52)67(63,64)56-46-40-19-23-60(30-43(40)53-32-54-46)37-17-21-59(22-18-37)29-34-6-2-3-7-39(34)33-10-12-35(48)13-11-33/h2-15,28,32,36-37,55H,16-27,29-31H2,1H3,(H,53,54,56)/t36-/m1/s1
- InChiKey:
YFAUSZFDWXUZEQ-PSXMRANNSA-N
External links
![]() 87251464 |
External search
![]() |
![]() |
![]() |
![]() |
![]() |
Bibliography (1)
Publication | Name |
---|---|
Karen Miller-Moslin, Bakary-Barry Toure, Michael Scott Visser, Naeem Yusuff, Novartis Ag. . Sulfonamides as inhibitors of bcl-2 family proteins for the treatment of cancer None. | 56 |
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
1 | 0 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
BCL2-Like / BAX | 7.57 | cancer | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 1000.30 g/mol | |||
HBA | 12 | |||
HBD | 2 | |||
HBA + HBD | 14 | |||
AlogP | 6.67 | |||
TPSA | 131.08 | |||
RB | 16 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 1 | 0 | 0 | 0 |
Pharmacological data
Bibliography | Name | Target | Competition | Assay type | Assay name | Cell line | Activity type | Activity |
---|---|---|---|---|---|---|---|---|
WO2011029842 | 56 | BCL2 P10415 |
|
Biochemical assay | Surface Plasmon Resonance | pIC50 (half maximal inhibitory concentration, -log10) | 7.57 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.5016 | Navitoclax | DB12340 | |
0.4007 | N-{2-[6-(2,4-DIAMINO-6-ETHYLPYRIMIDIN-5-YL)-2,2-DIMETHYL-3-OXO-2,3-DIHYDRO-4H-1,4-BENZOTHIAZIN-4-YL]ETHYL}ACETAMIDE | DB06899 | |
0.3774 | GDC-0349 | DB13072 | |
0.3768 | Sparsentan | DB12548 | |
0.3750 | Presatovir | DB12165 | |
0.3746 | Quinupristin | DB01369 | |
0.3696 | Sulfaisodimidine | DB13283 | |
0.3651 | 4-[(5-CHLOROINDOL-2-YL)SULFONYL]-2-(2-METHYLPROPYL)-1-[[5-(PYRIDIN-4-YL)PYRIMIDIN-2-YL]CARBONYL]PIPERAZINE | DB04673 | |
0.3624 | ABT-639 | DB15055 | |
0.3621 | (3R,4S)-1-{6-[3-(METHYLSULFONYL)PHENYL]PYRIMIDIN-4-YL}-4-(2,4,5-TRIFLUOROPHENYL)PYRROLIDIN-3-AMINE | DB07666 | |
0.3576 | (3R,4R)-1-{6-[3-(METHYLSULFONYL)PHENYL]PYRIMIDIN-4-YL}-4-(2,4,5-TRIFLUOROPHENYL)PIPERIDIN-3-AMINE | DB08164 | |
0.3567 | Lenacapavir | DB15673 | |
0.3563 | Encorafenib | DB11718 | |
0.3546 | PF-232798 | DB14813 | |
0.3533 | N-(2-(((5-CHLORO-2-PYRIDINYL)AMINO)SULFONYL)PHENYL)-4-(2-OXO-1(2H)-PYRIDINYL)BENZAMIDE | DB07800 |